| 000 | 01301 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250512162357.0 | ||
| 264 | 0 | _c19701007 | |
| 008 | 197010s 0 0 fre d | ||
| 022 | _a0430-0920 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMagnin, A | |
| 245 | 0 | 0 |
_a[Pharmacological properties of reserpine 3,5,3'-triiodothyroacetate]. _h[electronic resource] |
| 260 |
_bIl Farmaco; edizione scientifica _cMay 1970 |
||
| 300 |
_a362-85 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aCentral Nervous System _xdrug effects |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aEpinephrine _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHypnotics and Sedatives |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNorepinephrine _xpharmacology |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReserpine _xadministration & dosage |
| 650 | 0 | 4 |
_aSecologanin Tryptamine Alkaloids _xadministration & dosage |
| 650 | 0 | 4 |
_aThyroid Gland _xdrug effects |
| 650 | 0 | 4 | _aVasodilator Agents |
| 700 | 1 | _aNicod, B | |
| 700 | 1 | _aBourquin, C | |
| 700 | 1 | _aMagnin, P | |
| 773 | 0 |
_tIl Farmaco; edizione scientifica _gvol. 25 _gno. 5 _gp. 362-85 |
|
| 999 |
_c5452850 _d5452850 |
||